Proof of concept study: does fenofibrate have a role in sleep apnoea syndrome?
Bruckert
Eric
E
Service d'Endocrinologie et Métabolisme, Assistance Publique - Hôpitaux de Paris, Hôpital de la Pitié-Salpétrière, 75013 Paris, France. eric.bruckert@psl.aphp.fr
Duchêne
Emilie
E
Bonnefont-Rousselot
Dominique
D
Hansel
Boris
B
Ansquer
Jean-Claude
JC
Dubois
André
A
Gaymard
Bertrand
B
D001288:Attention; D004311:Double-Blind Method; D005260:Female; D011345:Fenofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008055:Lipids / Q000097:blood; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012890:Sleep; D012891:Sleep Apnea Syndromes / Q000188:drug therapy* / Q000503:physiopathology
D000960:Hypolipidemic Agents; D008055:Lipids; D010919:Placebos; D011345:Fenofibrate